Focused on molecular diagnostics for transplant patients, the company develops blood-based tests used to monitor organ rejection and guide post‑transplant care. Its flagship products, including AlloSure and AlloMap, are used by transplant centers to assess graft health without invasive biopsies. Inv...
This page tracks all publicly disclosed congressional trades in CareDx, Inc (CDNA), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 0 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |